Argentina: Following close of Bayer-Monsanto merger, still pending Argentina’s approval
German firm Bayer confirmed last Thursday that it had completed the purchase of multinational seed-maker Monsanto, in what will become one of the largest “Brand kills” in history, as the name of the American company first founded in 1901 will no longer be used.
The merger, which was announced in September 2016, finally came to a close after the antitrust authorities at the US Department of Justice gave their approval, though they imposed obligations on Bayer to sell many of its assets.
In Argentina, the National Commission for the Defense of Competition has not yet issued a decision in this regard and, therefore, both companies will continue to operate independently until the official authorization arrives.
“In Argentina, and until we obtain the final approval of the competent agencies in our country, the two companies will continue to operate independently and develop their activities as before the acquisition. That is to say, its operational and daily relationship with both Bayer and Monsanto, will remain as it has been to this day” Bayer said in the statement to the press.
Full Content: AgroVoz
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Assembles AI Experts to Shape Regulatory Framework
Sep 30, 2024 by
CPI
Brazil’s Supreme Court Orders Platform X to Pay $5 Million in Fines Before Service Can Resume
Sep 29, 2024 by
CPI
Oasis Ticket Price Surge Sparks Urgent Calls for Dynamic Pricing Reform
Sep 29, 2024 by
CPI
Grocers, Small Businesses Demand Fair Competition in Letters to Trump, Harris
Sep 29, 2024 by
CPI
Flipkart Sellers Sue Indian Antitrust Watchdog Over Competition Law Violation Findings
Sep 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh